Amoun Pharmaceutical Company S.A.E. is one of the largest and most recognized pharmaceutical company in Egypt that manufactures, markets and distributes branded generics of human and animal health products. Since its incorporation, Amoun’s strategy has been focused on creating a strong pharmaceutical industry that provides quality medicines to its patients and the communities in which it serves.


Our vision of becoming a National Company with international Standards drives our long and sustainable business and is essential in the way we determine our approach. We invest patiently in our assets while exercising a long term strategy, we improve the quality and the value of our assets by partnering with multinational companies and we enhance productivity by partnering with professional management teams, skillful labor and high end technology in order to help us reach our full potential. Once we commit to a strategic objective, we stick with it across all levels and functions in order to deliver on our promise.

We are convinced that our investors, partners and employees depend on us to protect their investments and deliver the level of returns needed to meet their financial obligations. By exercising a culture that strives to avoid undue risk, we are able to protect capital and increase shareholders’ value. Our Management Team also understands that our high standards of integrity places great value on doing the right things and on doing things right. We are proud that our efforts to build a great Company have been recognized locally and regionally by our competitors and our peers.

Amoun remains extremely well positioned to deliver greater results for investors and to grow its businesses and its regional opportunities. Amoun has a diverse platform that gives us exceptional access to compelling opportunities across a wide range of products and markets. An extraordinary leadership team with a relentless commitment to excellence provides the expertise and wisdom to guide our decisions. Finally, we have a proven approach to building value over a long-term strategy.

Our investment in the upgrade of our manufacturing facilities with the addition of a new top of the line sterile area is a prime example of our commitment to a long-time strategy. During a difficult time of political and economic instability, we continued to support a highly skillful labor force, a team of highly trained professionals and a great management team in achieving our operating synergies and in growing our business regionally, while taking a futuristic viewpoint to further fortify our investment in order to increase our equity value.

We thank our investors and partners for their confidence in our Company, and we thank our employees for committing their talent and expertise to our success. We look forward to reporting continued strong performance going forward.

Mohamed S. Roushdy
Chairman & CEO